Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. InvaTech Pharma Solutions, LLC
FDA Inspection
•InvaTech Pharma Solutions, LLC•June 9, 2023

InvaTech Pharma Solutions, LLC – FDA Inspection, Jun 9, 2023

Record Details

This FDA Inspection record concerns InvaTech Pharma Solutions, LLC, with an inspection on June 9, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
InvaTech Pharma Solutions, LLC
Inspection Date
June 9, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Syeda N. Mahazabin (FDA Associated Person)
View Company Profile

ID · 2d086648-ee7e-457c-a735-8d26296a25e8

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1209653
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

16
  1. 21 CFR 211.165(d)Acceptance criteria for sampling & testing
  2. 21 CFR 211.122(d)Label storage access limited to authorized personnel
  3. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  4. 21 CFR 211.142(b)Storage under appropriate conditions
  5. 21 CFR 211.160(b)Scientifically sound laboratory controls
  6. 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.22(d)Procedures not in writing, fully followed
  9. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  10. 21 CFR 211.122(d)Label storage access limited to authorized personnel

Showing 10 of 16 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of InvaTech Pharma Solutions, LLC

6
DateClassificationOfficeProject area
May 13, 2026Not classifiedNew Jersey District OfficeDrug Quality Assurance
February 7, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 28, 2017VAINew Jersey District OfficeGeneric Drug Evaluation
April 4, 2017Not classifiedNew Jersey District Office
November 8, 2016Not classifiedNew Jersey District Office
View all 6 other inspections on the company page
Other documents for InvaTech Pharma Solutions, LLC
  • FDA Inspection 1308318 - 2026-05-13
  • FDA Inspection 1079089 - 2019-02-07
  • FDA Inspection 1036723 - 2017-12-28
  • FDA Inspection 1011050 - 2017-04-04
  • FDA Inspection 991403 - 2016-11-08

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore InvaTech Pharma Solutions, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.